Medical insider reveals Alexander Isak’s Newcastle United return date – ‘worse than we feared’

New Newcastle United star Alexander Isak’s injury may be worse than initially feared by the Sweden medical staff.

That is the view of medical expert Ben Dinnery, who runs the Premier Injuries site and has a background in injury and data analysis.

Isak, who joined Newcastle in a club-record £63million deal from Real Sociedad in August, is set to miss the clash against Fulham on Saturday (1 October) after picking up a lower leg injury on international duty.

Newcastle

As relayed by Chronicle Live on Monday (26 September), the setback was initially described only as a “little feeling”.

But it is now understood that, following assessment, his status has been upgraded to a higher-grade injury.

Dinnery explained that the centre-forward could now miss up to three weeks of action.

“It was an issue that was flagged during a training session with Sweden,” he told Football Insider’s Adam Williams.

“It was a fairly non-descript lower leg problem. Initially, it was touted as a minor concern, more of a feeling as opposed to a sharp pull or pain. That is an indication that we are looking at a soft tissue or muscle problem.

“The player will be assessed, scanned and evaluated. It is maybe more worrisome than we first thought.

“The expectation is that we are maybe looking at potentially two or three weeks on the sidelines. That doesn’t come as any great surprise.

“He was thrown in at the deep end following the injury to Callum Wilson and hasn’t had the opportunity to adapt fully to the Premier League environment.

Newcastle

“It’s not unheard of for those who are coming into that situation to pick up knocks and niggles as they adapt and transition.

“Going from domestic to international football, you have different loads, environments, surfaces, climates, time zones. All of those will have some influence and impact in terms of these knocks and niggles.”

In other news, Newcastle United set sights on beating Everton to Nicolas Jackson deal.